P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)?

P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)?

Bibliographic Details
Main Authors: M. Calamac, N. Stanic, O. Djurmez, M. Dimitrijevic, J. Vukosavljevic, K. Serovic, J. Oblakovic-Babic, I. Minic, I. Bozovic-Spasojevic
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762300406X

Similar Items

Similar Items